Chemical Component Summary

NameBLEOMYCIN A2
SynonymsN1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE
Identifiersn/a
FormulaC55 H85 N17 O21 S3
Molecular Weight1,416.56
TypeNON-POLYMER
Isomeric SMILESCc1c(nc(nc1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](c2c[nH]cn2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCS(C)C)O
InChIInChI=1S/C55H85N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81,96H,7-13,15-16,56H2,1-6H3,(H2,57,76)(H2,59,82)(H2,60,88)(H,61,65)(H,62,84)(H,63,85)(H,66,87)(H,70,83)(H,71,86)(H2,58,69,72)/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1
InChIKeyZGCQRJQBETWECF-UAPAGMARSA-N

Chemical Details

Formal Charge0
Atom Count181
Chiral Atom Count19
Bond Count186
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB00290 
NameBleomycin
Groups
  • approved
  • investigational
DescriptionA complex of related glycopeptide antibiotics from <i>Streptomyces verticillus</i> consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0). It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A2 is used as the representative structure for Bleomycin.
Synonyms
  • Bleomycin hydrochloride
  • Bleocin
  • Bleomycin
  • Bleomicina
  • Bleomycinum
Brand Names
  • Blenoxane
  • Bleomycin for Injection USP
  • Blenoxane Pws 15unit
  • Bleomycin for Injection
  • Bleomycin
IndicationFor palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.
Categories
  • Amino Acids, Peptides, and Proteins
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Carbohydrates
ATC-CodeL01DC01
CAS number11056-06-7

Drug Targets

NameTarget SequencePharmacological ActionActions
DNA ligase 1MQRSIMSFFHPKKEGKAKKPEKEASNSSRETEPPPKAALKEWNGVVSESD...unknowninhibitor
DNA-unknowncleavage
DNA ligase 3MSLAFKIFFPQTLRALSRKELCLFRKHHWRDVRQFSQWSETDLLHGHPLF...unknowninhibitor
Bleomycin hydrolaseMSSSGLNSEKVAALIQKLNSDPQFVLAQNVGTTHDLLDICLKRATVQRAQ...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem6323238